Ag Biotech Issues With Mexico, Dairy Access To Canada Raised
The Alliance for Trade Enforcement is raising issues on ag biotech in Mexico and Canadian pharmaceutical actions as areas that need to be enforced under the U.S.-Mexico-Canada Agreement (USMCA). The full enforcement of intellectual property (IP) commitments under USMCA is key, the group said in a letter to U.S. Trade Representative Robert Lighthizer.
“The Government of Mexico's failure to approve these products threatens both trade with Mexico and U.S. farmers' access to important technologies. This could have a devastating effect on U.S. farmers and their customers in Mexico,” the group said.
Dairy issues were also raised by the group, with the letter pointing to Canada's announcement on distribution of dairy tariff-rate quotas (TRQs) “runs counter to various USMCA commitments including discouraging high-value food service or retail products from entering the market.” The group also said they are concerned Canada will not live up to eliminating their Class 7 pricing program and will “manipulate its agreed-upon trade obligations to protect its tightly controlled dairy market are unacceptable.”
The group also called out Canada's Patented Medicine Prices Review Board, saying it “continues to develop and implement unfair pricing and reimbursement regulatory schemes that do not fully account for the cost of research and development of innovative treatments.”